ABBOTT LABORATORIES
ABT
Latest Filing: Apr 29, 2026 • 25 Total Filings
Total Assets
2026$110.43B
Total Revenue
2026$11.16B
Net Income
2026$1.08B
Operating Cash Flow
2026$1.31B
Filing Year:
2025
Data Source:
Showing data from all document types
Filters:
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor